otitis-externa
发表于 2025-3-21 20:05:28
书目名称Disease Recurrence After Liver Transplantation影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0281259<br><br> <br><br>书目名称Disease Recurrence After Liver Transplantation影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0281259<br><br> <br><br>书目名称Disease Recurrence After Liver Transplantation网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0281259<br><br> <br><br>书目名称Disease Recurrence After Liver Transplantation网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0281259<br><br> <br><br>书目名称Disease Recurrence After Liver Transplantation被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0281259<br><br> <br><br>书目名称Disease Recurrence After Liver Transplantation被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0281259<br><br> <br><br>书目名称Disease Recurrence After Liver Transplantation年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0281259<br><br> <br><br>书目名称Disease Recurrence After Liver Transplantation年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0281259<br><br> <br><br>书目名称Disease Recurrence After Liver Transplantation读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0281259<br><br> <br><br>书目名称Disease Recurrence After Liver Transplantation读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0281259<br><br> <br><br>
debase
发表于 2025-3-22 00:09:12
ent and Survival. serves as a comprehensive reference for physicians and surgeons who take care of liver transplant recipients and a major addition to the literature detailing the current understanding of disease recurrence..978-1-4939-4137-7978-1-4939-2947-4
LEER
发表于 2025-3-22 01:06:24
http://reply.papertrans.cn/29/2813/281259/281259_3.png
纠缠
发表于 2025-3-22 07:18:56
http://reply.papertrans.cn/29/2813/281259/281259_4.png
完成才能战胜
发表于 2025-3-22 11:09:27
https://doi.org/10.1007/978-3-031-08961-9isease. Recurrence of alcoholic liver disease post-transplantation is a multifaceted problem that differs in scope from recurrence of viral hepatitis, autoimmune hepatitis, and primary sclerosing cholangitis. Multidisciplinary treatment plans that begin pretransplant and continue into the post-trans
使迷惑
发表于 2025-3-22 13:07:00
Ivica Milevski,Ekaterina Ivanovas are limited for recurrent PSC. For these important entities affecting PSC patients after liver transplantation, we review the current published data on epidemiology, diagnostic criteria, risk factors, graft and patient survival, and treatment of recurrent PSC.
使迷惑
发表于 2025-3-22 18:36:44
https://doi.org/10.1007/978-3-319-27905-3urvival (~70 %). The UNOS data also suggested that the survival improved after the publication of Milan criteria in the United States. There is an ongoing debate whether Milan criteria could be expanded without having an adverse effect on tumor-free survival. Published studies suggest that HCC patie
AGATE
发表于 2025-3-22 22:11:51
http://reply.papertrans.cn/29/2813/281259/281259_8.png
门窗的侧柱
发表于 2025-3-23 03:19:26
http://reply.papertrans.cn/29/2813/281259/281259_9.png
压迫
发表于 2025-3-23 06:16:20
Raymond Charles Rauscher,Salim Momtazmodal therapies including neoadjuvant chemotherapy and/or radiation, and surgical exploration followed by LTX offer patient survival rates comparable to LTX done for other liver disease etiologies in a select group of patients. At this time, LTX for cholangiocarcinoma should be performed using stric